Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
701.00    11.00 (1.59%)
Bid:
692.00
Ask:
710.00
Spread: 18.00 (2.601%)
Market Cap: £247.03m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Portfolio Update

30 Apr 2020 12:41

RNS Number : 5196L
B.P. Marsh & Partners PLC
30 April 2020
 

30th April 2020 

 

 

B.P. Marsh & Partners Plc 

("B.P. Marsh", "the Company" or "the Group") 

 

Portfolio Update

 

Repayment of Loan:

B.P. Marsh (AIM: BPM), the specialist investor in early stage financial services businesses, is pleased to note the recent receipt of a £2m Loan Repayment from Nexus Underwriting Management Limited ("Nexus").

 

The Company provided Nexus with a £2m Revolving Credit Facility in April 2019 (the "Loan Facility") as part of a wider £16m fundraising exercise, alongside the global investment firm HPS Investment Partners LLC. This was undertaken in order to provide Nexus with sufficient capital to pursue its growth strategy via value accretive acquisitions.

 

The Loan Facility was drawn down in full and has now been repaid by Nexus, eight months earlier than the scheduled repayment date. The Loan Facility will remain in place until December 2020.

 

The Loan Facility is in addition to a further £4m facility that the Group provided to Nexus in July 2017, which is due for repayment by January 2024.

 

The Group holds an aggregate Nexus shareholding of 17.6%, having bought an initial shareholding of 5% in August 2014. Since the Group's initial investment, Nexus has become one of the largest independently owned Managing General Agencies in the UK insurance market, growing from approximately £50m of premium income in 2014 to a budgeted £345m of premium income in 2020. This premium income is generated across various specialty areas including Financial Lines, Reinsurance, Trade Credit, Marine and Aviation insurance.

 

When the Group made its first investment in Nexus, it was operating one London office. Nexus now has offices in 9 countries across Europe, America and Asia.

 

In addition, on 9th  March 2020 Nexus announced that its independent broking arm, Xenia Broking Group Limited ("Xenia"), completed the acquisition of the trade credit business of Howden UK Group Limited ("Howden"), part of Hyperion Insurance Group Ltd. Xenia will integrate Howden's trade credit business with its existing trade credit broking operations, making it one of the largest independent trade credit insurance brokers in the UK.

 

Chief Investment Officer, Daniel Topping, commented on the repayment: "Given the unprecedented challenges currently faced by the UK and Global economies, it is testament to the strength of Nexus, its management and entire team that it is able, not only to continue to pursue its growth strategy via the acquisition of Howden's trade credit business, but also that it is able to access funding on commercially favourable terms.

 

"Nexus is not immune to the impact of Covid-19, but the Group has been pleased by the response of everyone at Nexus to adapt to these challenges and work towards solidifying the long-term strength of Nexus. At B.P. Marsh we have been pleased to see this approach replicated throughout our portfolio. Whilst it is currently difficult to provide long-term impact forecasts, we believe the approach taken by our portfolio's management teams has been sensible and proportionate, and underpins our long-term partnership-led approach to investment."

 

Covid-19:

B.P. Marsh continues to monitor closely the ongoing impact of the current Covid-19 pandemic. Whilst it is too early to predict with any accuracy the long-term impact, the Group's management team is working closely with each portfolio company and its management to ensure that each of them is well positioned to mitigate the short term impact of this situation.

 

At this juncture, the Group believes each portfolio company is adequately resourced to weather the challenges currently presented by Covid-19. The Group is focussed on cash flow and considers that it has sufficient resources available, including the £2m loan repayment from Nexus, together with access to a £3m loan facility, to support investee companies if necessary. 

 

We continue to operate effectively, with all management and employees working remotely. This shift in our working arrangements has not presented any significant challenges, as the team was already in the habit of liaising with portfolio companies across multiple locations and time zones. Our portfolio companies have also implemented remote working arrangements and have demonstrated that earlier investment into systems and business continuity plans have enabled these arrangements to be implemented with minimal impact.

 

Annual Results:

B.P. Marsh anticipates that it will publish its Annual Results on 9th June 2020 as previously announced. The Group will provide a further update on the impact of Covid-19 within the Annual Results. 

 

For further information, please visit www.bpmarsh.co.uk or contact: 

 

B.P. Marsh & Partners Plc

Brian Marsh OBE / Sinead O'Haire

 

+44 (0)20 7233 3112

Panmure Gordon (UK) Limited

Atholl Tweedie / Charles Leigh Pemberton / Ailsa MacMaster

 

+44 (0)20 78862500

Tavistock

Jos Simson / Simon Hudson / Tim Pearson

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

 

Notes to Editors: 

B.P. Marsh's current portfolio contains seventeen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk. 

 

Since formation over 25 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for approaching ten years. 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFUBBGDSCXXDGGG
Date   Source Headline
28th Oct 20107:00 amRNSHalf Yearly Report
24th Sep 20107:00 amRNSNotice of Interim Results
22nd Jul 20102:23 pmRNSCompletion of U.S. Risk (UK) Limited Investment
21st Jul 201012:28 pmRNSResult of AGM
22nd Jun 20109:35 amRNSReplacement - Notice of Annual General Meeting
22nd Jun 20107:00 amRNSNotice of Annual General Meeting
10th Jun 201011:05 amRNSReplacement - Investment in U.S. Risk (UK) Limited
10th Jun 20107:00 amRNSInvestment in U.S. Risk (UK) Limited
9th Jun 20103:22 pmRNSDirectors' Loan
2nd Jun 20107:00 amRNSFinal Results
7th May 20107:00 amRNSNotice of Final Results
21st Jan 20107:00 amRNSDisposal
21st Jan 20107:00 amRNSAcquisition
11th Jan 201012:25 pmRNSDirector's Dealing
14th Dec 200910:16 amRNSDirector's Dealing
27th Oct 20097:00 amRNSInterim Results
26th Oct 20093:26 pmRNSHolding(s) in Company
30th Sep 20097:00 amRNSNotice of Interim Results
23rd Jul 200910:41 amRNSAnnual Report and Accounts
21st Jul 20097:00 amRNSResult of AGM
18th Jun 20094:07 pmRNSNotice of AGM
9th Jun 20099:28 amRNSInvestee Company, Hyperion, Announces Acquisition
3rd Jun 20097:00 amRNSLoans to Investee Company
3rd Jun 20097:00 amRNSFinal Results
18th May 20099:52 amRNSChange of Adviser
6th May 200910:58 amRNSNotice of Results
6th Apr 20093:40 pmRNSHolding(s) in Company
26th Mar 200910:11 amRNSHolding of Shares by a Director
2nd Feb 20097:00 amRNSDirectorate Change
9th Dec 20084:23 pmRNSDirector/PDMR Shareholding
4th Dec 20083:26 pmRNSDirectorate Change
3rd Dec 20084:53 pmRNSDirector/PDMR Shareholding
1st Dec 20083:05 pmRNSChange of Registered Office
18th Nov 20083:06 pmRNSDirector/PDMR Shareholding
12th Nov 200812:42 pmRNSDirector/PDMR Shareholding
28th Oct 20087:00 amRNSInterim Results
6th Oct 20082:16 pmRNSNotice of Interim Results
1st Oct 20087:00 amRNSAppointment of Nominated Adviser
24th Jul 20082:24 pmRNSResult of AGM
25th Jun 20087:00 amRNSNotice of AGM
5th Jun 20087:00 amRNSFinal Results
7th May 20082:33 pmRNSNotice of Results
2nd Apr 20089:05 amRNSHyperion partners with 3i
20th Mar 20087:00 amRNSInvestment in Trillium
11th Mar 20087:01 amRNSInvestment in Business Broker
25th Feb 20084:17 pmRNSDirectorate Change
14th Feb 20081:26 pmRNSFurther re: Disposal
12th Feb 20087:01 amRNSDisposal
4th Feb 20082:46 pmRNSIncreased Investment in Summa
27th Nov 20077:01 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.